Huber Capital Management LLC Takes $1.76 Million Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Huber Capital Management LLC bought a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 28,670 shares of the medical instruments supplier’s stock, valued at approximately $1,762,000. Huber Capital Management LLC owned approximately 0.85% of Utah Medical Products at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Brandes Investment Partners LP grew its position in shares of Utah Medical Products by 17.8% in the 4th quarter. Brandes Investment Partners LP now owns 162,969 shares of the medical instruments supplier’s stock valued at $10,018,000 after acquiring an additional 24,604 shares during the period. Geode Capital Management LLC grew its holdings in Utah Medical Products by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 97,937 shares of the medical instruments supplier’s stock worth $6,022,000 after purchasing an additional 857 shares during the period. Hotchkis & Wiley Capital Management LLC grew its holdings in Utah Medical Products by 128.3% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier’s stock worth $5,956,000 after purchasing an additional 50,030 shares during the period. State Street Corp increased its position in Utah Medical Products by 0.9% during the third quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock worth $5,434,000 after buying an additional 694 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in Utah Medical Products by 14.8% in the fourth quarter. JPMorgan Chase & Co. now owns 79,703 shares of the medical instruments supplier’s stock valued at $4,899,000 after buying an additional 10,292 shares during the period. 69.60% of the stock is currently owned by institutional investors and hedge funds.

Utah Medical Products Trading Down 0.4 %

Shares of NASDAQ UTMD opened at $55.78 on Thursday. The company has a market capitalization of $183.07 million, a P/E ratio of 14.12 and a beta of 0.06. Utah Medical Products, Inc. has a 12 month low of $55.50 and a 12 month high of $77.33. The stock has a 50 day moving average of $59.32 and a 200-day moving average of $62.60.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be issued a $0.305 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.22 annualized dividend and a yield of 2.19%. Utah Medical Products’s dividend payout ratio is currently 30.89%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.